(PharmaNewsWire.Com, October 02, 2017 ) Helicobacter pylori (H. pylori) is gram-negative, aerobic bacteria mostly found in the stomach. The bacterium plays an essential role in maintaining the stomach ecology. H. pylori infection is caused when spiral-shaped bacteria attacks the stomach lining. The bacterium is associated with gastritis and gastric ulcers. It is also linked to stomach cancer and duodenal ulcers. Most of the H. pylori infections are harmless, but these bacteria are also responsible for most of the stomach ulcers and small intestine infections.
Publisher's analysts forecast the global helicobacter pylori diagnostics market to grow at a CAGR of 8.23% during the period 2017-2021. For more information about this report: http://www.reportsweb.com/global-helicobacter-pylori-diagnostics-market-2017-2021 . Covered in this report The report covers the present scenario and the growth prospects of the global helicobacter pylori diagnostics market for 2017-2021. To calculate the market size, the report considers new installations, sales, volume, and value of H. pylori diagnostics market.
The market is divided into the following segments based on geography: - Americas - APAC - EMEA
Publisher's report, Global Helicobacter Pylori Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
